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• Proteome of airway secretions derived from mock- and hRSV-infected WD-PBEC cultures.
• A polarised secretome in uninfected WD-PBECs, skewed in hRSV-infected cultures.
• CXCL6, CXCL16, CECACAM1 and CSF3 induced only upon hRSV-infection.
• Detection of CXCL6, CXCL16 and CSF3 in NPAs from hRSV-positive children.
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Novel Immune Modulating (CXCL6, CXCL16,
CSF3) and Antiviral (CEACAM1) Proteins*□S
Olivier Touzelet‡§, Lindsay Broadbent§, Stuart D. Armstrong‡¶, Waleed Aljabr‡,
Elaine Cloutman-Green**, Ultan F. Power§ §§, and Julian A. Hiscox‡¶‡‡¶¶
The respiratory epithelium comprises polarized cells at
the interface between the environment and airway tis-
sues. Polarized apical and basolateral protein secretions
are a feature of airway epithelium homeostasis. Human
respiratory syncytial virus (hRSV) is a major human patho-
gen that primarily targets the respiratory epithelium. How-
ever, the consequences of hRSV infection on epithelium
secretome polarity and content remain poorly under-
stood. To investigate the hRSV-associated apical and ba-
solateral secretomes, a proteomics approach was com-
bined with an ex vivo pediatric human airway epithelial
(HAE) model of hRSV infection (data are available via Pro-
teomeXchange and can be accessed at https://www.ebi.
ac.uk/pride/ with identifier PXD013661). Following infec-
tion, a skewing of apical/basolateral abundance ratios
was identified for several individual proteins. Novel mod-
ulators of neutrophil and lymphocyte activation (CXCL6,
CSF3, SECTM1 or CXCL16), and antiviral proteins (BST2
or CEACAM1) were detected in infected, but not in unin-
fected cultures. Importantly, CXCL6, CXCL16, CSF3
were also detected in nasopharyngeal aspirates (NPA)
from hRSV-infected infants but not healthy controls.
Furthermore, the antiviral activity of CEACAM1 against
RSV was confirmed in vitro using BEAS-2B cells. hRSV
infection disrupted the polarity of the pediatric respira-
tory epithelial secretome and was associated with im-
mune modulating proteins (CXCL6, CXCL16, CSF3)
never linked with this virus before. In addition, the anti-
viral activity of CEACAM1 against hRSV had also never
been previously characterized. This study, therefore,
provides novel insights into RSV pathogenesis and en-
dogenous antiviral responses in pediatric airway
epithelium. Molecular & Cellular Proteomics 19: 793–
807, 2020. DOI: 10.1074/mcp.RA119.001546.
The epithelial lining fluid is essential in regulating the ho-
meostasis of the airways. Apical secretions contain proteins
associated with anti-oxidative, anti-protease, anti-microbial,
and anti-inflammatory functions (1–5), and provide the first
line of defense against inhaled particulates, including bacteria
and viruses. Analysis of respiratory secretions by proteomics
demonstrated alterations of the protein composition in
chronic airway diseases, such as chronic obstructive pulmo-
nary disease (COPD)1, asthma and cystic fibrosis (CF) (6–9).
Moreover, proteome modifications were observed in bron-
choalveolar lavage fluids (BALF) or nasopharyngeal aspirates
(NPAs) from human immunodeficiency virus (HIV)-seroposi-
tive adults (10), and in hRSV-infected children (11), respec-
tively. The respiratory epithelium basolateral side juxtaposes
deeper lung tissues. Proteins secreted basolaterally impact
on the lung sub-epithelial structures and cells, such as se-
rous/mucous glands, fibroblasts, smooth muscle, blood ves-
sels or immune cells. Thus, alterations of the apical and
basolateral airway secretions are likely to reflect pathogenic
states and play a key role in disease progression.
hRSV is a major cause of severe acute lower respiratory
tract infection (ALRI) in young infants, the immunocompro-
mised and the elderly. It has a high burden in children 5
years old, with 34 million new ALRI episodes each year and
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up to 200,000 deaths (12). hRSV primarily targets the respi-
ratory epithelium and has been extensively characterized in a
model of well-differentiated pediatric airway epithelial cell
(HAE) cultures (13–20). In this system, the provision of an
air-liquid interface to confluent human primary nasal or bron-
chial epithelial cells grown on solid permeable supports drives
differentiation into pseudostratified columnar mucociliary ep-
ithelium that mimics the morphology, physiology and polarity
of human respiratory epithelium in vivo (13–20). RSV infection
of HAE cultures recapitulates many of the features associated
with hRSV infection in vivo (reviewed in (21)). However, the
impact of hRSV infection of the airway epithelium on the
overall protein secretome is unknown. Therefore, the HAE
model provides an ideal platform to address the proteome of
airway secretions, thereby providing extensive information on
the molecular changes associated with infection. Importantly,
HAE cultures provide easily accessible apical and basolateral
sides, thereby allowing analysis of airway secretions in both
directions, in contrast to NPAs or BALF, which, for practical
reasons can only inform changes associated with the apical-
facing epithelial surface.
This study evaluated the impact of hRSV on airway epithe-
lium secretions from pediatric HAE cultures, defined as well-
differentiated pediatric primary bronchial epithelial cells (WD-
PBECs), by characterizing the protein composition of the
apical and basolateral secretomes upon infection relative to
mock-infected control cultures, using quantitative proteomics
(LC-MS/MS). Importantly, novel proteins associated with RSV
infection were identified, including proteins with immune
modulating or antiviral activities. Furthermore, our HAE find-
ings reflected changes in NPAs from hRSV-infected infants.
EXPERIMENTAL PROCEDURES
Cells—HEp-2 cells were kindly provided by Ralph Tripp (University
of Georgia) and grown at 37 °C with 5% CO2 in Dulbecco’s modified
Eagle’s medium (DMEM) high glucose (4.5 g/L) supplemented with
5% (v/v) FBS and penicillin (100 IU/ml) and streptomycin (100 g/ml)
(Pen Strep, Life Technologies, UK). BEAS-2B cells (ATCC CRL-9609)
were grown in DMEM low glucose (1 g/L) supplemented with 5% (v/v)
FBS, penicillin (100 IU/ml) and streptomycin (100 g/ml). Commer-
cially available primary pediatric bronchial epithelial cells (donors
aged 2–9 years) (Lonza, Switzerland) were grown on Transwells
(Corning, NY; 6.5 mm diameter, 0.4 ?m pore size) as previously
published (20) to generate well-differentiated pseudostratified cul-
tures. The use of such commercial primary cells in this study did not
require ethical approval. After initiating “air-liquid interface” culture,
the basolateral medium (Promocell, UK) was replaced with fresh
medium and any liquid or mucus on the apical surface was aspirated
every 2 days. The apical side was washed prior to infection with 200
l serum free (SF)-DMEM (no additives). Both the virus stocks and the
cell lines were confirmed to be mycoplasma-free using Lookout my-
coplasma PCR detection kit.
Virus—The hRSV BT2a clinical isolate was isolated from an infant
hospitalized with bronchiolitis and passaged 3 times in HEp-2 cells
(22). hRSV/eGFP was obtained from Prof. Ralph Tripp and Prof.
Michael Teng (University of South Florida) and propagated in HEp-2
cells. Briefly, hRSV stocks were grown in HEp-2 cells (MOI 0.1) and
harvested by cell scraping when extensive cytopathic effects (CPE)
were obvious (80–90% of cells floating/rounded up and extensive
syncytia). Following sonication (10 min, 4 °C, intensity 9) and clarifi-
cation of the lysate at 3200  g for 10 min at 4 °C the supernatant was
aliquoted and snap-frozen and stored in liquid nitrogen.
RSV Titration - Tissue Culture Infectious Dose (TCID50)—RSV titers
for virus stocks, in apical rinses and BEAS-2B supernatants were
determined in HEp-2 cells. In brief, HEp-2 cells were seeded at 5 
104 cells/well on 24 well plates. The following day 200 l of a 10-fold
serial dilution of the virus stock, apical rinse or BEAS-2B supernatant
were added to the HEp-2 cells in quadruplicate (from 101 to 108
dilutions). Following incubation for 2 h at 37 °C the inoculum was
removed and 1 ml DMEM (High glucose) supplemented with 1% FBS
(v/v) and penicillin (100 IU/ml) and streptomycin (100 g/ml) was
added. Cultures were incubated for 7 days at 37 °C and then exam-
ined for signs of CPE. Titers were calculated using the Kärber method
and reported as log10 TCID50/ml (23).
RSV Infection of WD-PBECs—WD-PBEC cultures from each donor
were infected with hRSV BT2a at a multiplicity of infection (MOI) of
0.1, using SF-DMEM (no additives)-treated cells as mock infection. To
calculate the MOI cultures from one well from each donor were
trypsinized and enumerated. Just before infection, the apical side was
washed twice with 200 l SF-DMEM (no additives) and fresh medium
was added to the basolateral side. Cultures were infected on the
apical side by incubation for 2 h at 37 °C 5% CO2 with 200 l of virus
stock diluted in SF-DMEM (no additives) beforehand, or with medium
only (mock). Subsequently, the virus inoculum was removed, and the
apical side was rinsed 4 times with SF-DMEM (no additives). The
cultures were kept at 37 °C 5% CO2 and monitored daily by light
microscopy for CPE.
Sample Collection from WD-PBECs—After infection, the basolat-
eral medium (300 l) and apical wash (200 l) from hRSV BT2a- and
mock-infected cultures were collected at 24, 48, 72, 96, and 120 h
post-infection (hpi) for each donor, snap-frozen in liquid nitrogen and
stored at 80 °C. The apical wash was generated by incubation with
200 l of SF-DMEM (no additives) at RT for 5 min followed by gentle
pipetting up and down three times, whereas fresh medium was added
in the basolateral compartment. In order to remove cell debris and
inactivate the virus before sample preparation for MS, the apical and
basolateral samples were centrifuged at 3000  g for 10 min at 4 °C
and the supernatant was heat-treated for 10 min at 95 °C.
Sample Preparation for Label-free Mass Spectrometry—Apical
(135 l) and basolateral (180 l) samples collected at 96 h post-
infection (hpi) from control and hRSV-infected WD-PBEC cultures
were prepared for analysis by NanoLC MS ESI MS/MS (LC-MS/MS).
Soluble proteins were precipitated by addition of an equal volume of
ice-cold 30% (w/v) trichloroacetic acid (TCA) in acetone with incuba-
tion at 20 °C for 2 h. Samples were centrifuged at 12,000  g for 10
min (4 °C) to pellet proteins. Pellets were washed three times with
ice-cold acetone and allowed to air dry. Protein pellets were then
re-suspended in 50 mM ammonium bicarbonate, 0.1% (w/v) RapiGest
SF (Waters, Elstree, UK). Samples were further processed and ana-
lyzed by NanoLC MS ESI MS/MS as previously described (24). Sam-
ples were heated at 80 °C for 10 min, reduced with 3 mM DTT at 60 °C
for 10 min, cooled, then alkylated with 9 mM iodoacetamide (Sigma)
for 30 min (room temperature) protected from light; all steps were
performed with intermittent vortex-mixing. Proteomic-grade trypsin
1 The abbreviations used are: COPD, chronic obstructive pulmo-
nary disease; RSV, respiratory syncytial virus; HAE, human airway
epithelial model; WD-PBECs, well-differentiated pediatric bronchial
epithelial cells; BALF, bronchoalveolar lavage fluid; NPA, nasopha-
ryngeal aspirate; CF, cystic fibrosis; ALRI, airway lower respiratory
tract infection.
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(Sigma) was added (0.2 g) and incubated at 37 °C overnight. To
remove RapiGest SF, the samples were precipitated using 1% (v/v)
TFA at 37 °C for 2 h and centrifuged at 12,000  g for 1 h (4 °C). The
peptide supernatant was desalted using C18 reverse-phase stage tips
(Thermo Scientific Pierce) according to the manufacturer’s instruc-
tions. Samples were desalted and reduced to dryness and re-sus-
pended in 3% (v/v) acetonitrile, 0.1% (v/v) TFA for analysis by MS. All
reagents are supplied by Sigma-Aldrich unless stated otherwise.
NanoLC MS ESI MS/MS Analysis—Peptides were analyzed by
on-line nanoflow LC using the Ultimate 3000 nano system (Dionex).
Samples were loaded onto a trap column (Acclaim PepMap 100, 2
cm  75 m inner diameter, C18, 3 m, 100 Å) at 9 l/min with an
aqueous solution containing 0.1% (v/v) TFA and 2% (v/v) acetonitrile.
The trap column was set in-line an analytical column (Easy-Spray
PepMap® RSLC 50 cm  75 m inner diameter, C18, 2 m, 100 Å)
fused to a silica nano-electrospray emitter (Dionex). The column was
operated at a constant temperature of 35 °C and the LC system
coupled to a Q-Exactive mass spectrometer (Thermo Fisher Scien-
tific). Chromatography was performed with a buffer system consisting
of 0.1% formic acid (buffer A) and 80% acetonitrile in 0.1% formic
acid (buffer B). The peptides were separated by a linear gradient of
3.8–50% buffer B over 90 min at a flow rate of 300 nl/min. The
Q-Exactive was operated in data-dependent mode with survey scans
acquired at a resolution of 70,000 at m/z 200. Scan range was 300 to
2000 m/z. Up to the top 10 most abundant isotope patterns with
charge states 2 to 5 from the survey scan were selected with an
isolation window of 2.0 Th and fragmented by higher energy colli-
sional dissociation with normalized collision energies of 30. The max-
imum ion injection times for the survey scan and the MS/MS scans
were 250 and 50 ms, respectively, and the ion target value was set to
1E6 for survey scans and 1E5 for the MS/MS scans. MS/MS events
were acquired at a resolution of 17,500. Repetitive sequencing of
peptides was minimized through dynamic exclusion of the sequenced
peptides for 20 s.
Protein Identification and Quantification—Label-free quantitation
was performed using MaxQuant software (version1.5.3.3 (25)) with its
internal search engine Andromeda (26). Precursor mass and fragment
mass were searched with mass tolerance of 4.5 and 20 ppm respec-
tively. All other settings were default. The search included variable
modifications of oxidation (methionine) and protein N-terminal acety-
lation, and fixed modification of carbamidomethyl (cysteine). Enzyme
specificity was set to trypsin (Trypsin/P), minimal peptide length was
set to 7 amino acids and a maximum of two mis-cleavages were
allowed. The false discovery rate (FDR) was set to 0.01 for peptide
and protein identifications. The Andromeda search engine was con-
figured for a database containing human proteins and hRSV (Uniprot
release-2015_01, 20226 entries (27)). The software further includes a
decoy database as well as common contaminants database to de-
termine the false discovery rate and to exclude false positive hits
because of contamination by proteins from different species. For
label-free quantification (LFQ) analysis, “multiplicity” was set to one.
Matching between runs was enabled. Only unmodified and unique
peptides were utilized. The mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE
(28) partner repository with the data set identifier PXD013661. Param-
eter search and acceptance criteria, a summary of the raw mass
spectrometric data, and lists of identified peptides and proteins are
also included in supplemental Tables S1, S2, S3, and S4, respec-
tively. Averaged LFQ intensity values were used to calculate protein
ratios. Contaminants, keratins and host proteins only identified by
unique peptides were excluded. Each protein was characterized by
its percentage of sequence coverage, its molecular weight, the num-
ber of unique peptides used for identification and its abundance
(label-free quantification [LFQ]) in the apical and basolateral samples.
Proteins detected in at least 2 donor replicates, with at least two
unique peptides per replicate, were retained for further analysis.
Prediction of the Apical and Basolateral Secretome—The secre-
tome analysis followed an approach recently reported (29), which
used several algorithmic methods to predict the presence of a signal
peptide (SP) and/or a transmembrane region (TM) based on the amino
acid sequence of a protein. In this study, SignalP4.1 (http://www.cbs.
dtu.dk/services/SignalP/), an update from SignalP4.0 (30), Phobius
(http://phobius.sbc.su.se/) (31), SPOCTOPUS (http://octopus.
cbr.su.se/index.php) (32) and TMHMM2.0 (http://www.cbs.dtu.dk/
services/TMHMM/) (33) were used to identify proteins predicted to
carry SPs and/or TMs, and secretomeP2.0 (http://www.cbs.dtu.dk/
services/SecretomeP/) (34) to distinguish proteins secreted in a non-
classical fashion, all using default settings (35). SignalP4.1 and
TMHMM2.0 only focused on the prediction of SP or TM, respectively,
whereas Phobius and SPOCTOPUS combined the prediction of SP
and TM (Phobius SP/TM and SPOCTOPUS SP/TM). All five algo-
rithms are trained against specific data sets to discriminate between
the type of protein feature or the secretory pathway involved. These
programs were used to classify proteins following a majority-decision
based method, whereby at least two out of three methods must
predict that a protein carries a specific topological feature (supple-
mental Fig. S3). Therefore, all identified proteins in the apical wash
and basolateral medium of mock- and hRSV BT2a-infected WD-
PBEC cultures were organized accordingly as secreted via a signal
peptide, secreted in a non-classical pathway, membrane or intracel-
lular proteins. When required, exosome analysis was performed by
searching the Exocarta database (http://www.exocarta.org/) (36).
Subjects and Clinical Specimen Collection—Nasopharyngeal aspi-
rates (NPAs) were collected from six hRSVA- and six hRSVB-positive
children (1–9 years-old, median age  2.5, IQR  2.5) admitted to
Great Ormond Street Hospital for children in London. hRSV diagnosis
was confirmed by the Film Array multiplex polymerase chain reaction
(PCR) system respiratory panel (Biomerieux diagnostics, Basing-
stoke, UK). This panel detects the 20 most common respiratory
pathogens; adenovirus, coronavirus HKU1, coronavirus NL63, coro-
navirus OC43, human metapneumovirus, human rhinovirus/Enterovi-
rus, influenza A, influenza A H1, influenza A H1–2009, influenza A/H3,
influenza B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza
virus 3, parainfluenza virus 4, HRSV, Bordetella pertussis, Chlamydo-
phila pneumoniae, and Mycoplasma pneumoniae. For this study they
represented discarded samples and there was no identifying infor-
mation (supplemental Table S5), and as such did not require ethical
approval. Twelve NPA samples from hRSV-negative children of sim-
ilar age (1–9 years-old, median age  2, IQR  2.25), obtained
during the same hRSV season, were used as controls. The NPA
sampling was carried out as per the hospital’s guidelines. Briefly, a
catheter was inserted into the nose, directed posteriorly and toward
the opening of the external ear, in order to reach the posterior phar-
ynx. Suction was applied and the catheter was slowly withdrawn
using a rotating movement, remaining less than 10 s in the nasophar-
ynx. The catheter was then rinsed with a small volume of sterile 0.9%
saline solution to ensure adequate specimen volume. Samples were
stored at 80 °C until use.
Immunofluorescence of WD-PBEC Cultures—Immunofluores-
cence staining (IF) was carried out as previously described (20).
Briefly, at 120 hpi the cultures were fixed with PBS 4% paraform-
aldehyde (v/v; Sigma-Aldrich) for 20 min. Fixed WD-PBEC cultures
were stored in 70% ethanol (v/v in dH2O) at 4 °C until used. The
cultures were rinsed 1 with PBS (pH 7.4) and permeabilized with
PBS 0.2% Triton X-100 (v/v; ThermoFisher Scientific, UK) for 1 h at
RT. After blocking for 30 min with 0.4% BSA (v/v in PBS, pH7.4)
(Sigma Aldrich), cultures were stained with anti--tubulin Cy3-conju-
gated monoclonal antibody (ciliated cell marker) (Abcam, ab11309)
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diluted at 1:200, and anti-RSV F 488-conjugated antibody (Millipore,
Nottingham, UK, MAB8262X) diluted at 1:500, incubated for 1 h at
37 °C. Goblet cells were stained with a rabbit anti-Muc5ac (Abcam,
UK, ab78660) diluted at 1:100 and incubated overnight at 4 °C, fol-
lowed by a goat anti-rabbit IgG conjugated to Alexa fluor 647 (Ther-
mofisher, A21245), diluted at 1:500 and incubated 1h at 37 °C. All
antibodies were diluted in 0.4% BSA. Following treatment with DAPI-
mounting medium (Vectashield, Vector Labs, UK), fluorescence was
detected in the cultures by UV microscopy (Nikon Eclipse 90i). Total
RSV-infected and ciliated cells were enumerated in 5 fields of view
per culture at 60 magnification.
Western Blotting and ELISA—Apical and basolateral samples from
control and infected WD-PBEC cultures, and NPAs were clarified at
3000  g for 10 min at 4 °C. Protein concentration in NPA samples
was estimated by PierceTM BCA assay (Thermofisher scientific).
Twelve l/lane of each sample from hRSV BT2a-infected cultures, a
pooled sample from mock-infected cells (4 l each), and 10 g/lane
of NPAs were then resolved by 10 or 12% SDS-PAGE and transferred
to PVDF membranes (Millipore) using a Bio-Rad semi-dry transfer
apparatus. An aliquot of sucrose-gradient purified hRSV A2 strain or
a cell lysate from HEp-2 cells infected with hRSV A2 (MOI  1) for 24 h
were used as positive controls. Immobilized host and virus proteins
were detected with the following primary antibodies: rabbit anti-CSF3
(ab181053, Abcam), goat anti-hRSV proteins (ab20745, Abcam),
mouse anti-hRSV matrix protein (M024, 1:500) and nucleoprotein
(mab0015, 1:500), both kindly provided by Prof. Paul Yeo, Durham
University, mouse anti-hRSV M2-1 (ab94805, Abcam) and mouse
anti-hRSV Fusion protein (ab94968, Abcam). Unless stated, all pri-
mary antibodies were diluted 1:1000 in tris-buffered saline supple-
mented with 2% milk. Two HRP-conjugated secondary antibodies
(goat anti-rabbit IgG [A6154] and anti-mouse IgG [A4416]) were ob-
tained from Sigma and one from Abcam (rabbit anti-goat IgG
[ab6741]). All were detected by enhanced chemiluminescence (ECL)
with the Clarity™ Western ECL Blotting Substrate from Bio-Rad
(Hemel Hempstead, UK). In all cases, the apparent molecular weights
were estimated using Color Prestained Protein Standard (11–245
kDa) from New England Biolabs (Ipswitch, UK). CXCL6 and CXCL16
were quantified with Human Quantikine ELISA Kits (R&D systems,
Abingdon, UK), as per suppliers’ recommendations.
Functional Assay—A polyclonal rabbit anti-CEACAM1 antibody
(Agilent, Stockport, UK, IS526530), known to block its activity (37, 38),
and a polyclonal rabbit isotype control antibody (R&D, AB-105-C)
were dialyzed in PBS to remove any traces of sodium azide, as per
manufacturer’s instructions (Slide-a-lyser cassettes, MWCO  10K,
#66380, ThermoFisher Scientific). Dilutions of antibodies were pre-
pared in PBS with dilution factors of 1:2, 1:3, 1:5, 1:10, and 1:100 from
the dialyzed stocks. BEAS-2B cells were seeded in 96-well plates at
104 cells/well the day before infection and infected in triplicate (50
l/well) with combinations of hRSV/eGFP (MOI  3) and dilutions of
the antibodies/PBS. After two h of virus adsorption, cells were
washed once with PBS (100 l/well) and incubated for 72 h in 100
l/well of DMEM (supplemented with 1% FBS and pencillin/strepto-
mycin) containing the appropriate dilution of antibodies/PBS. The
infection was followed by fluorescence imaging every 24 hpi (3 pic-
tures taken per well) and the fluorescence was analyzed with ImageJ
software (fluorescence intensity and percentage of eGFP coverage
per field view). Supernatant (25 l/well) was also collected every 24
hpi and virus titration carried out by TCID50. Twenty five l/well were
replaced with fresh medium containing the appropriate antibody/PBS
treatment.
Experimental Design and Statistical Rationale—For LC-MS/MS
analysis, three independent biological replicate experiments were
performed using WD-PBECs derived from three individual donors. For
each donor, apical washes and basolateral medium were collected
from WD-PBECS cultures, which were either mock-treated (mock) or
infected with hRSV BT2a. Therefore, a total of 12 samples (collected
at 96 hpi) were analyzed by LC-MS/MS.
All bioinformatics analyses of protein abundance were performed
using PERSEUS 1.6.1.3 software. For comparative analysis protein
abundance values were log2-transformed. The significantly enriched
apical and basolateral proteins were highlighted with volcano plots
(two-sample t test with a permutation-based FDR method) and further
selected using an adjusted p value 0.05 and a fold change 2 as
filtering criteria. Log2-transformed individual values or triplicate means
were z-score-normalized prior to hierarchical clustering. Gene ontology
biological process (GOBP) enrichment analysis was achieved with a
Fisher exact test (Benjamini-Hochberg FDR 0.2%) and the cellular com-
ponent enrichment analysis (GOCC) was achieved with a Fisher exact
test (p value  0.01). Exosome analysis was performed by searching the
Exocarta database (http://www.exocarta.org/). When required, classifi-
cation of proteins in BPs was achieved with Funrich v3.0 software.
Each apical and basolateral sample tested by LC-MS/MS (derived
from each donor and either mock-treated or infected) was also vali-
dated by Western blotting, whereas the corresponding cultures (fixed
at 120 hpi) were analyzed by immunofluorescence. For ELISA quan-
tification in samples from WD-PBECs cultures, statistical analysis was
performed with a two-tailed paired Student’s t test, and for the NPAs
from healthy and hRSV-positive children a Mann-Whitney test was
used. In the case of the CEACAM1 functional assay, statistical anal-
ysis was carried out with a 2-way ANOVA test and the results pre-
sented are representative of three independent experiments. For all
statistical tests utilized p values 0.05 were considered significant.
RESULTS
hRSV Growth Kinetics, Cell Tropism, and Viral Protein De-
tection—WD-PBEC cultures (n  3 donors) were infected with
hRSV BT2a (MOI  0.1) or mock infected. hRSV growth
kinetics, cell tropism and cytopathogenesis (CPE) were deter-
mined. Virus release was detected in apical rinses at 24 hpi
and peaked at 96 hpi (Fig. 1A). hRSV primarily infected ciliated
cells but not goblet cells (Fig. 1B and supplemental Fig. S1).
There was no obvious CPE observed in cultures from any donor
(data not shown). To further extend these findings, the presence
of viral proteins was investigated by LC-MS/MS analysis of
apical and basolateral samples collected at 96 hpi from mock-
and hRSV-infected cultures. Five viral proteins were identified
by at least two unique peptides, in infected cultures only from all
donors. These included the hRSV matrix (M), fusion (F0), phos-
phoprotein (P), nucleoprotein (N), M2-1 proteins, in order of
abundance (Table I). The RNA-dependent RNA polymerase (L)
protein was detected in samples from 2 donors. In general,
detection was restricted to the apical side, and confirmed by
Western blotting analyses for viral proteins (Fig. 1C). Unexpect-
edly, hRSV M protein was detected by LC-MS/MS in the baso-
lateral medium from one donor (Table I), but was not confirmed
by Western blotting. Overall, these findings were consistent with
the viral growth kinetics and the strict apical release of virions
previously reported for hRSV in HAE models of adult or pediatric
origin, and for both nasal and bronchial cells (13–19).
Characterization of the Secretomes from Control and hRSV-
infected Cultures—The apical and basolateral secretomes
were determined by LC-MS/MS analysis of samples collected
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TABLE I
hRSV proteins detected by LC-MS/MS at 96 hpi in the apical washes or basolateral medium of hRSV-infected WD-PBECs
Apical Basolateral




Matrix 63.5/3 25 81.2 24.36/1 1
Fusion (F0) 11.6/3 25 53.3 N.D.f N.D.
Phosphoprotein 9.3/3 12 85.9 N.D. N.D.
Nucleoprotein 9.4/3 22 64.7 N.D. N.D.
Matrix M2-1 5.9/3 5 60.3 N.D. N.D.
RNA-dependent RNA polymerase L 0.38/2 4 4.4 N.D. N.D.
aPercentage of the total abundance of all the viral proteins detected, averaged between replicates
bNumber of replicates the protein was identified in
cNumber of unique peptides used for protein identification
dThe percentage of sequence coverage for the identified protein
eAbundance intensity expressed as Log2
f N.D.  not detected
FIG. 1. hRSV targets ciliated cells but not goblet cells, and leads to a productive infection. A, WD-PBEC cultures (n  3 donors, in
duplicate) were infected with hRSV (MOI  0.1) or mock infected. Apical rinses were taken every 24 h and titrated using HEp-2 cells by TCID50.
B, At 120 h post-infection (hpi) cultures were fixed with 4% paraformaldehyde, ciliated, goblet and infected cells were stained with
anti--tubulin (red), anti-Muc5ac (white) and FITC-conjugated anti-RSV (green) antibodies, respectively. Cultures were examined by fluorescent
microscopy at x63 magnification. C, Apical washes and basolateral medium collected at 96 hpi from infected cultures, and pooled samples
from mock-infected cultures were analyzed individually by Western blotting (12 l/lane). Ten l/lane of a sucrose-gradient purified hRSV A2
stock was used as control. Immunoblot analyses was carried out using a polyclonal anti-hRSV antibody (upper panel) and monoclonal
antibodies specific for the matrix protein (M), nucleoprotein (N), fusion (F) and M2-1 (lower panel), followed by appropriate HRP-conjugated
secondary antibodies for enhanced chemiluminescence detection.
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from mock- and hRSV-infected WD-PBEC cultures (96 hpi). A
total of 959 host proteins were identified by at least 2 unique
peptides and in cultures from 2 donors (supplemental Table
S6). Unexpectedly, based on their predicted topology, intra-
cellular (n  437) and membrane (n  129) proteins repre-
sented more than half the protein pool (Figs. 2A and supple-
mental Fig. S3), as opposed to mainly secreted proteins (n 
257, signal peptide; n  136 non-classical pathway), and this
was also observed in the apical and basolateral sides sepa-
rately (supplemental Fig. S4). A GOCC enrichment analysis
(Fisher exact test, Benjamini-hochberg FDR 0.1%) further val-
idated this finding. In control and infected cultures, proteins
predicted to be intracellular, membrane or secreted were
mostly enriched in proteins assigned to cell parts/cytoplasm,
the plasma membrane or the extracellular space/vesicle lu-
men, respectively, and the converse was true with regards to
the depleted proteins (Fig. 2B). Although intriguing, the de-
tection of many intracellular, membrane and unconventionally
secreted proteins in apical and basolateral secretions was in
line with other reports (1, 3, 5, 39). Their presence could be a
consequence of cell sloughing, particularly in the apical side
during hRSV infection (14–17), or of exosomal secretion,
which is a feature of differentiated HAE (2) and hRSV-infected
undifferentiated epithelial cells from the bronchial and small
airway (40). Indeed, an overlap with a human exosome data-
base (n  6516, http://www.exocarta.org/) revealed that 413
intracellular (out of 437), 111 membrane (out of 129) and 119
(out of 136) unconventionally secreted proteins had been
identified in previous exosomal data sets (Fig. 2C). This is
consistent with the presence of these proteins in the basolat-
eral secretome, considering the physical separation between
cells and medium.
FIG. 2. Classification of proteins by predicted topology, GOCC enrichment and exosome analyze. A, Number of proteins for each
category (x axis). Using predictive software, all the proteins identified in mock- and hRSV-infected WD-PBEC cultures of each patient (n  3)
were combined and categorized into proteins secreted via a signal peptide or in a non-classical pathway, and cellular proteins with either
intracellular or membrane localization. B, GOCC enrichment of the proteins predicted to be intracellular, membrane or secreted (classical and
non-classical fashion), which identified the five most significantly enriched (1, red bars) and depleted (1, blue bars) cellular compartments
in each protein group. x axis, gene ontology enrichment factor. Only GO classifications with a FDR  1% are shown. C, Venn-diagrams
showing the overlap between several categorises of secretome proteins and a human exosome database (Exocarta, http://www.exocarta.org/).
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Secretome Directionality and Homeostatic Processes—To
assess whether the polarity of healthy WD-PBEC cultures was
reflected by their protein composition, apical and basolateral
secretomes were compared with one another. In control cul-
tures, 226 apical and 90 basolateral proteins were found to be
unique (Fig. 3A), whereas a volcano plot analysis revealed that
157 proteins were significantly enriched in one side or the
other (p  0.05, supplemental Fig. S5A). A hierarchical clus-
tering of the abundance patterns clearly validated this dichot-
omy (Fig. 3C and supplemental Fig. S6A), confirming a polar-
ized secretome. Interestingly, basic homeostatic processes
were distinct between the apical and basolateral secretomes
of uninfected cultures, as revealed by a GOBP enrichment
analysis performed on unique and enriched proteins (Fisher
exact test, p value  0.01). The apical secretome was signif-
icantly associated with proteins involved in lipid metabolism,
o-glycosylation, signaling, transport, regulation of cell activa-
tion, calcium/ion homeostasis, response to stimulus, regula-
tion of enzymes activity, sugar metabolism, cellular processes
and other BPs (supplemental Fig. S7A and S7B). In contrast,
the basolateral proteins were significantly associated with the
regulation of metabolic and cellular processes, the regulation
of cell death, cell contraction/movement and various meta-
bolic and other pathways (supplemental Fig. S7C and S7D).
Hence, under homeostatic conditions the airway secretome
from WD-PBECs cultures was polarized in protein composi-
tion and biological functions, thus corroborating previous ob-
servations in HAE cultures (5).
Impact of hRSV on WD-PBEC Culture Secretomes—To
determine whether hRSV impacted normal airway epithelial
FIG. 3. The secretome of WD-PBECs cultures is directional. A and B, Venn diagrams showing the distribution of apical and basolateral
unique proteins in control (A) and infected (B) WD-PBECs cultures. C, Hierarchical clustering of proteins whose abundance was significantly
changed between the apical and basolateral sides of mock and infected cultures (p value 0.05, fold change 2). Only the 229 proteins
identified by volcano plot analysis are shown (supplemental Fig. S5). Log-2 transformed abundance values were Z-score-normalized for each
replicate, which is a measure of the deviation from the sample mean. The hierarchical clustering was performed with the rows indicating
individual proteins and the columns individual replicate (green, low abundance; red, high abundance; gray, undetected). See supplemental Fig.
S6 for more detailed heatmaps of labeled proteins. D, Using predictive software (see supplemental Fig. S3), proteins from mock- and
hRSV-infected WD-PBEC cultures (black and white bars, respectively) of each patient (n  3) were categorized based on their expected
topologies (y axis), and the total number in each category is shown (x axis).
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functions, the protein composition and directionality of the
secretomes were compared between mock and infected cul-
tures. More proteins were detected upon infection (n  912)
compared with control cultures (n  810) (Fig. 3D), and this
increase was more pronounced in the basolateral side (sup-
plemental Figs. S4). Interestingly, the number of uniquely
apical or basolateral proteins was also altered in hRSV-
infected cultures (Fig. 3A and 3B), as was the number of
significantly enriched proteins on either side (supplemental
Fig. S5B).
In view of these observations and as directional protein
secretion is characteristic of a healthy epithelium, apical/ba-
solateral protein abundance ratios were calculated to deter-
mine disruptions in secretion patterns associated with
RSV-infected airway epithelium (supplemental Fig. S8). Inter-
estingly, 34 proteins were identified with altered secretion
patterns, whereby their polarity of secretion was changed in
infected cultures (Fig. 4A). Altered abundance ratios were also
observed for several of the proteins significantly enriched
under normal homeostatic conditions (Fig. 4B and supple-
mental Table S6). Moreover, many of those affected proteins
were associated with biological processes (BPs) enriched
under healthy conditions (supplemental Table S7). For in-
stance in the apical side, affected BP groups included calci-
um/ion homeostasis, lipid or sugar metabolism, signaling, and
responses to chemical or mechanical stimuli. Similarly, altered
basolateral proteins were implicated mainly in various cellular/
metabolic processes and their regulation, and the regulation
of cell death. These data suggested that hRSV perturbed
several homeostatic BPs by affecting the protein equilibrium
between apical and basolateral sides and, by extension, dis-
rupted normal airway epithelium functions.
In addition to these exciting observations, a further 65 host
proteins were specifically induced (n  52) or no longer de-
FIG. 4. Host proteins with secretion patterns most affected by hRSV infection. A, Hierarchical clustering of proteins whose polarity of
secretion was changed upon infection (n  34). Log-2 transformed mean abundance values between replicates were Z-score-normalized. The
hierarchical clustering was performed with the rows indicating individual proteins and the columns averaged replicate (yellow, low abundance;
red, high abundance; gray, undetected). B, Graphical representation of the host proteins whose abundance ratios were the most disrupted
upon infection (n  20, delta fold change 2, see supplemental Table S6). For each protein (x axis), the bars represent the apical/basolateral
ratios (left y axis) and the dots indicate the corresponding abundance (right y axis), in control (blue) and virus-infected (red) WD-PBEC cultures.
Both protein abundance (LFQ intensity) and abundance ratios were plotted on a Log2 scale. Proteins were separated based on their predicted
cellular location and the data were displayed for the apical (top) and basolateral (bottom) side.
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tectable (n  13) at 96 hpi (Fig. 5A and supplemental Table
S6). Functional classification showed that most of the 13
undetectable proteins were involved in physiological pro-
cesses, such as cell communication, signal transduction and
transport (Fig. 5B). Of note, groups of BPs involving calcium/
ion transport and o-glycosylation were affected via the loss of
SLC2A1/ATP6V1E1 and MUC13, respectively (supplemental
Table S7). hRSV-induced proteins were mainly implicated in
energy pathways, metabolism, signal transduction, cell com-
munication and immune responses (Fig. 5C). Of these, 17
proteins were associated with significantly enriched BPs in-
dicative of viral infection: immune processes, response to
stimulus, cell migration and the negative regulation of cell
differentiation (Fig. 6 and supplemental Table S9). They in-
cluded several neutrophil (CXCL6, CXCL10, and IL6) and lung
T cell (CXCL16) chemoattractants (41), a neutrophil growth
factor (CSF3) and 2 proteins with antiviral properties against
Influenza or hMPV (BST2 and CEACAM1) (37, 38, 42). In
addition, SECTM1, which is implicated in signal transduction
and cell communication (Fig. 5C), was previously identified as
a neutrophil activator (43). As a major pathological component
of hRSV-induced disease is the large infiltration of neutro-
phils in the lungs (44), these data are extremely relevant in
the context of hRSV pathophysiology. In an exciting devel-
opment, whereas CXCL10 and IL6 were previously associ-
ated with responses to hRSV infection in WD-PBECs (15)
and children (45, 46), an association between hRSV infec-
tion and CXCL6, CSF3, CXCL16, SECTM1 and BST2 is a
novel observation. Importantly, these novel associations
were confirmed to be strictly infection-specific, as none of
these proteins were present in the proteome of airway se-
FIG. 5. Host proteins whose secretion was specifically induced (n  53) or shut down (n  13) upon infection. A, The hierarchical
clustering was performed with log-2 transformed abundance values, which were averaged for each group then Z-score-normalized. The rows
indicate individual proteins and the columns individual replicate (yellow, low abundance; red, high abundance; gray, undetected). B, C,
Classification of shut down (B) and induced (C) proteins based on their associated biological processes (BPs, y axis) and the number of proteins
in each BP (x axis). Grouping was achieved with Funrich v3.0 and proteins are labeled for each BP.
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cretions (supplemental Table S10) from healthy patients (47)
or uninfected HAE cultures (1–3, 5, 39).
Quantification of CXCL6 and CXCL16 by ELISA and Valida-
tion of CEACAM1 as a Novel hRSV Antiviral Factor—Neutro-
phil and T cell infiltrations are hallmarks of hRSV pathogenesis
in infants. As CXCL6 and CXCL16 are chemotactic for neu-
trophils and T cells, respectively, validating our secretome
data was imperative to further support a potential role for
these proteins in hRSV pathogenesis. Therefore, changes in
the abundance of CXCL6 and CXCL16 were confirmed by
ELISA. CXCL6 concentrations were significantly increased in
the apical side of infected WD-PBECs compared with mock-
infected cultures (Fig. 7A). CXCL16 was more abundant in the
basolateral side under homeostatic conditions and this differ-
ence was amplified following hRSV infection (Fig. 7B).
CEACAM1 has both transmembrane and secreted iso-
forms, is up-regulated upon hRSV infection in A549 and un-
differentiated primary bronchial epithelial cells, and displays
an antiviral activity against influenza virus and hMPV (37, 38,
48, 49), a close relative of hRSV. To determine whether
CEACAM1 has antiviral activity against hRSV, BEAS-2B cells
were infected with hRSV/eGFP (MOI  3) in the presence or
absence of serial dilutions of an antibody that blocks
CEACAM1 function (37, 38). BEAS-2B is a more relevant
epithelial cell line (compared with A549) to study RSV and has
been shown to express CEACAM1 (49, 50). Anti-CEACAM1
treatment led to a significant increase in fluorescence inten-
sity supplemental Fig. S9A, S9B, and S9C) and percentage of
fluorescence coverage of the monolayer (supplemental Fig.
S9D and S9E) which resulted in an accelerated hRSV release
at 48 hpi, compared with controls (Fig. 8A and 8B). This effect
was dependent on the Ab dilution and the time of infection.
eGPF intensity and percentage of coverage are surrogates
for RSV gene transcription kinetics whereas virus TCID50
titrations measure replication-competent virus release, and
virus transcription evidently occurs before assembly and
release. Therefore, peak effects of anti-CEACAM1 treat-
ment on RSV replication at 24 hpi (eGFP intensities and
coverage) and at 48 hpi (TCID50 titrations) is consistent with
the relative kinetics of gene transcription and virus release
These data are consistent with an antiviral activity of
CEACAM1 against hRSV.
FIG. 6. Enriched BP associated with hRSV-induced proteins. A, The most significantly enriched BP (1, y axis) associated with
hRSV-induced proteins were identified by GOBP enrichment, and further divided in functional groups. x axis, gene ontology enrichment factor.
Only GO classifications with a p value 0.01 are shown. B, Venn-diagrams showing the overlap between the hRSV-induced proteins
specifically associated with the enriched BPs (n  17) and the four functional groups.
FIG. 7. CXCL6 and CXCL16 secre-
tions increased following RSV infec-
tion of WD-PBECs. Apical CXCL6 (A)
and basolateral CXCL16 (B) concentra-
tions were determined by ELISA at 96
hpi from mock- and hRSV-infected WD-
PBECs (n  3; mean 	 S.D.). A p value
0.05 indicated statistical significance
(Student’s t test).
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Protein Content in NPAs from hRSV-infected Infants Re-
flects the WD-PBECs Data—To determine whether CXCL6,
CXCL16 and CSF3 induction following hRSV infection in WD-
PBECs corresponded with hRSV-infected infants, NPAs from
hRSV-positive and uninfected infants (supplemental Table
S10) were tested by ELISA and immunoblotting. NPA use was
dictated by appropriate sample availability. However, al-
though the WD-PBEC cultures were derived from tracheo-
bronchial cells, NPA clinical samples were considered appro-
priate, as evidence suggests that nasal epithelium is an
appropriate surrogate for bronchial epithelium in relation to
hRSV infection (17). The concentrations of CXCL6 (Fig. 9A)
and CXCL16 (Fig. 9C) were significantly increased in NPAs
from hRSV-positive infants. There was a small but significant
correlation between CXCL6 concentrations and viral load (Ct
values) in NPAs (Fig. 9B), suggesting that the release of CXCL6
might be dependent on the kinetic of viral replication. Similarly,
CSF3 was detected by Western blotting in most samples from
sick children compare with controls (Fig. 9D–9F). Furthermore,
hRSV matrix protein was detected by Western blotting only in
hRSV-positive samples with Ct values 20 cycles.
DISCUSSION
The proteome of airway secretions was unknown in the
context of an acute respiratory virus infections. This study
determined the impact of hRSV on the protein composition of
airway epithelium secretions. For this purpose, WD-PBECs
were infected with a clinical isolate of hRSV (BT2a), or mock-
infected, and the apical and basolateral secretomes were
profiled using quantitative proteomics.
The data indicated that the directional nature of the airway
secretome at homeostasis (5) was markedly disrupted by
hRSV. This was primarily evidenced by the altered polarity of
secretion of a large panel of proteins (Fig. 4), encompassing
multiple biological processes, and was indicative of a poten-
tially dysfunctional epithelial barrier. Indeed, such epithelial
leakage resembles the increased paracellular permeability ob-
served in HAE cultures originating from asthmatic patients
(51) or in polarized monolayers with CF defects (52). In those
models, disruption of epithelial tight junction integrity was
evident, and was associated with decreased transepithelial
electrical resistance (TEER) and increased permeability to
fluorescently labeled macromolecules. Interestingly, these ef-
fects were also noted after hRSV infection in polarized respi-
ratory epithelial cell monolayers (53), and bronchial, but not
nasal, HAE cultures (17, 18). One consequence of a “leaky”
epithelium, in the HAE model at least, was to exacerbate an
otherwise compartmentalized inflammatory response (54, 55),
by increasing the exposure of sub-epithelial tissues to luminal
antigens (allergens and immunogenic ligands).
Furthermore, disordered immune responses is consistent
with the exacerbated inflammation of the bronchiolar and
alveolar regions observed in severe hRSV-associated pathol-
ogies (reviewed in (56)). hRSV-associated inflammation is
thought to be Th2-mediated and characterized by a large
infiltration of neutrophils in the airways (44), consistent with
FIG. 8. Blocking CEACAM1 activity increases hRSV release in BEAS-2B. hRSV titers in the supernatant of infected BEAS-2B cells (MOI 
3), which were treated with different dilutions of anti-CEACAM1 blocking Ab, an isotype Ab control or PBS, during the course of the infection
(x axis). Dilution 1:2 (A) and 1:5 (B) are shown and titers were expressed as Log10 (TCID50/ml) (y axis). Statistical analysis was carried out with
a 2-way ANOVA test and p values 0.05 were considered significant (*, p  0.05; **, p  0.01). The results presented are representative of
three independent experiments.
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elevated IL-6, CXCL8, and CXCL10 responses (15, 45, 46).
Altered CXCL6, CSF3, SECTM1, and CXCL16 secretions
were, therefore, highly relevant in this context considering
their functions as modulators of neutrophil and T cell activity
(Fig. 5). Conversely, the loss of MUC13 secretion following
infection was intriguing because it is a transmembrane mu-
cosal protein with pro-inflammatory properties (57). CSF3 is a
neutrophil growth factor, whereas CXCL6 is chemotactic for
neutrophils and binds the same receptors as CXCL8 (CXCR1/
CXCR2) (58). SECTM1 is a membrane/secreted airway epi-
thelium-derived protein that was shown to sustain an ampli-
fying loop of neutrophilic inflammation during pneumococcal
pneumonia (43). CXCL16 is an epithelium-derived chemokine
that recruits and activates lung T cells via the CXCR6 receptor
(59). CXCL6 and CXCL16 were particularly noteworthy be-
cause of their increased concentrations in NPAs from hRSV-
positive children (Fig. 9A and 9C) and their association with
several chronic lung pathologies, such as idiopathic pulmo-
nary fibrosis (IPF), CF, chronic rhinosinusitis (CRS) and
asthma. In CF and CRS patients, CXCL6 was detected in lung
epithelium goblet cells and was a more potent neutrophil
chemoattractant than CXCL8, whereas treatment with an anti-
CXCL6 antibody reduced neutrophil influx and inflammation in
a mouse model of IPF (59–63). Similarly, CXCR6 was ex-
pressed on lung-infiltrating Th2 cells in a mouse model of
asthma (62) and in asthmatic patients (61). In addition,
whereas MUC13 exacerbated the responsiveness of intestinal
epithelial cell lines to multiple TLR ligands, leading to in-
creased IL-8 and TNF- production (57), its expression was
only up-regulated in NPAs from patients with severe hRSV-
associated disease, in contrast to milder cases (64). Overall,
our data suggest that CXCL6, CXCL16, CSF3 and, to a lesser
extent, SECTM1 and MUC13, may constitute important but
previously unidentified drivers/modulators of neutrophil infil-
tration and recruitment and/or activation of Th2 cells to the
lungs during acute hRSV infection.
FIG. 9. Detection of host and viral proteins in NPAs from hRSV-positive children. NPA samples from hRSVA-positive (n  6) and
hRSVB-positive (n  6) infants were analyzed by ELISA and Western blotting and compared with non-infected control. Samples were collected
and prepared as per methods. CXCL6 quantities (A) were measured by ELISA, and correlation between CXCL6 concentration and viral load
(Ct values) was calculated by linear regression analysis (B). CXCL16 quantities (C) were also measured by ELISA. Eight g protein/lane were
analyzed by immunoblotting with antibodies against hRSV M protein and CSF3. Patient numbers are indicated above (See supplemental Table
S10) (D, E, F). Whole cell lysate from hRSV A2-infected HEp-2 cells was used as a positive control (). Ct values from the diagnostic tests are
indicated. Statistical significance was established using a Mann-Whitney test.
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In addition to identifying novel hRSV-induced mediators
associated with recruitment of immunopathogenic immune
cells, this work also highlighted direct cytophysiological and
antiviral responses of airway epithelium to hRSV infection. For
example, BST2 and CEACAM1, which have known antiviral
properties against HIV, influenza virus or hMPV, were spe-
cifically induced upon hRSV infection (37, 38, 42) and in the
case of CEACAM1 this correlated with previous data in
A549 and undifferentiated primary bronchial epithelial cells
(49). Importantly, this is the first description of the involve-
ment of CEACAM1 in anti-hRSV defense (Fig. 8). Like BST2,
CEACAM1 is normally a membrane-associated protein, but
its secretion may be explained by soluble isoforms of the
protein (48). Active cleavage of native CEACAM1 from cell
surfaces is also possible, especially in such a protease-rich
environment. In this study, CEACAM1 was identified as a novel
secreted factor with antiviral properties against hRSV in the
epithelium environment. Another novel observation was the loss
of detection of two membrane transporters, SLC2A2 and
ATPV6E6, which are involved in maintaining cation/Ca2 home-
ostasis (Fig. 5A and supplemental Table S8). Indeed, efficient
mucociliary clearance relies essentially on coordinated cilia
movement, which is partly controlled by tight regulation of in-
tracellular and extracellular levels of Ca2 (65, 66). Altering the
expression/secretion of these host factors suggests that hRSV
might affect Ca2 levels, which in turn could lead to dysregu-
lation of cilia beating. This is consistent with the ability of hRSV
to induce cilia beating dyskinesia, at least in the HAE model (18).
A reduced mucociliary clearance may indeed exacerbate hRSV-
associated pathologies because it drives the transport of in-
haled particles and pathogens trapped in the mucus out of the
airways and toward the oropharynx.
In conclusion, global analysis of the apical and basolateral
secretomes following RSV infection revealed novel interac-
tions between hRSV and the airway epithelium. It also iden-
tified novel anti-hRSV innate immune responses with potential
for therapeutic intervention. The application of proteomics to
our hRSV/WD-PBEC model, therefore, provided extensive
new insights into hRSV/host interactions and the rationale for
therapeutic target discovery.
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